Guardant Health Inc (GH)
18.88
+0.30
(+1.61%)
USD |
NASDAQ |
May 03, 16:00
18.90
+0.02
(+0.13%)
After-Hours: 20:00
Guardant Health Enterprise Value: 2.273B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.273B |
| May 02, 2024 | 2.236B |
| May 01, 2024 | 2.197B |
| April 30, 2024 | 2.165B |
| April 29, 2024 | 2.188B |
| April 26, 2024 | 2.086B |
| April 25, 2024 | 2.063B |
| April 24, 2024 | 2.177B |
| April 23, 2024 | 2.085B |
| April 22, 2024 | 2.115B |
| April 19, 2024 | 1.930B |
| April 18, 2024 | 2.003B |
| April 17, 2024 | 1.969B |
| April 16, 2024 | 1.941B |
| April 15, 2024 | 2.051B |
| April 12, 2024 | 2.194B |
| April 11, 2024 | 2.245B |
| April 10, 2024 | 2.297B |
| April 09, 2024 | 2.308B |
| April 08, 2024 | 2.242B |
| April 05, 2024 | 2.117B |
| April 04, 2024 | 2.180B |
| April 03, 2024 | 2.369B |
| April 02, 2024 | 2.502B |
| April 01, 2024 | 2.436B |
| Date | Value |
|---|---|
| March 28, 2024 | 2.482B |
| March 27, 2024 | 2.157B |
| March 26, 2024 | 2.124B |
| March 25, 2024 | 2.056B |
| March 22, 2024 | 2.071B |
| March 21, 2024 | 2.109B |
| March 20, 2024 | 2.154B |
| March 19, 2024 | 2.155B |
| March 18, 2024 | 2.095B |
| March 15, 2024 | 2.131B |
| March 14, 2024 | 2.207B |
| March 13, 2024 | 2.284B |
| March 12, 2024 | 2.240B |
| March 11, 2024 | 2.283B |
| March 08, 2024 | 2.373B |
| March 07, 2024 | 2.389B |
| March 06, 2024 | 2.218B |
| March 05, 2024 | 2.256B |
| March 04, 2024 | 2.274B |
| March 01, 2024 | 2.280B |
| February 29, 2024 | 2.284B |
| February 28, 2024 | 2.251B |
| February 27, 2024 | 2.348B |
| February 26, 2024 | 2.423B |
| February 23, 2024 | 2.335B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.930B
Minimum
Apr 19 2024
17.02B
Maximum
Feb 12 2021
6.975B
Average
6.585B
Median
Dec 03 2019
Enterprise Value Benchmarks
| Exact Sciences Corp | 12.85B |
| Illumina Inc | 19.17B |
| Delcath Systems Inc | 119.14M |
| CytoSorbents Corp | 38.69M |
| Progyny Inc | 2.690B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -187.04M |
| Revenue (Quarterly) | 155.05M |
| Total Expenses (Quarterly) | 352.56M |
| EPS Diluted (Quarterly) | -1.58 |
| Gross Profit Margin (Quarterly) | 59.68% |
| Profit Margin (Quarterly) | -120.6% |
| Earnings Yield | -22.67% |
| Normalized Earnings Yield | -22.67 |